scholarly journals Inheritance of Factor VII and Protein S Deficiency Together with Factor V Leiden Mutation

2016 ◽  
Vol 6 (1) ◽  
pp. 64-68
Author(s):  
Zafer Bıçakcı ◽  
Lale Olcay
2003 ◽  
Vol 20 (1) ◽  
pp. 1-5 ◽  
Author(s):  
Yasar Dogan ◽  
Denizmen Aygun ◽  
Yelda Yılmaz ◽  
Guler Kanra ◽  
Gulten Secmeer ◽  
...  

2020 ◽  
pp. 1-2
Author(s):  
Niranjan Mayadeo ◽  
Anusha V Devalla

Protein C and S are important mediators in coagulation. Their deficiency poses a high susceptibility of thrombosis, fetal losses, recurrent abortion, pre-eclampsia, abruption, severe morbidity and mortality. Pre-eclampsia seen in these women usually presents at an early gestational age and usually with high severity. The incidence varies as per the ethnicity with higher prevalence in the west. In Asian countries, Factor V Leiden mutation is seen more commonly associated with thromboembolic disorders. Aspirin and Low molecular weight Heparin is the mainstay of treatment. We describe a rare case of Protein S deficiency (50% activity) in pregnancy presented with previous recurrent pregnancy losses in a 32 year old woman.


2003 ◽  
Vol 20 (1) ◽  
pp. 1-5 ◽  
Author(s):  
Yasar Dogan ◽  
Denizmen Aygun ◽  
Yelda Yılmaz ◽  
Guler Kanra ◽  
Gulten Secmeer ◽  
...  

Blood ◽  
1998 ◽  
Vol 92 (7) ◽  
pp. 2353-2358 ◽  
Author(s):  
Ida Martinelli ◽  
Pier Mannuccio Mannucci ◽  
Valerio De Stefano ◽  
Emanuela Taioli ◽  
Valentina Rossi ◽  
...  

AbstractDeficiency of the naturally occurring anticoagulant proteins, such as antithrombin, protein C and protein S, and activated protein C resistance due to the factor V Leiden gene mutation is associated with inherited thrombophilia. So far, no direct comparison of the thrombotic risk associated with these genetic defects is available. In this study, we wish to compare the lifetime probability of developing thrombosis, the type of thrombotic symptoms, and the role of circumstantial triggering factors in 723 first- and second-degree relatives of 150 index patients with different thrombophilic defects. We found higher risks for thrombosis for subjects with antithrombin (risk ratio 8.1, 95% confidence interval [CI], 3.4 to 19.6), protein C (7.3, 95% CI, 2.9 to 18.4) or protein S deficiency (8.5, 95% CI, 3.5 to 20.8), and factor V Leiden (2.2, 95% CI, 1.1 to 4.7) than for individuals with normal coagulation. The risk of thrombosis for subjects with factor V Leiden was lower than that for those with all three other coagulation defects (0.3, 95% CI, 0.1 to 1.6), even when arterial and superficial vein thromboses were excluded and the analysis was restricted to deep vein thrombosis (0.3, 95% CI, 0.2 to 0.5). No association between coagulation defects and arterial thrombosis was found. The most frequent venous thrombotic manifestation was deep vein thrombosis with or without pulmonary embolism (90% in antithrombin, 88% in protein C, 100% in protein S deficiency, and 57% in factor V Leiden), but a relatively mild manifestation such as superficial vein thrombosis was common in factor V Leiden (43%). There was a predisposing factor at the time of venous thromboembolism in approximately 50% of cases for each of the four defects. In conclusion, factor V Leiden is associated with a relatively small risk of thrombosis, lower than that for antithrombin, protein C, or protein S deficiency. In addition, individuals with factor V Leiden develop less severe thrombotic manifestations, such as superficial vein thrombosis.


Sign in / Sign up

Export Citation Format

Share Document